Keyphrases
Clinical Management
100%
Multidrug Resistance Phenotype
100%
Multidrug Resistance
100%
Breast Cancer Progression
100%
Breast Cancer Recurrence
100%
P-glycoprotein (P-gp)
66%
Overexpression
33%
Blood-brain Barrier
33%
Breast Cancer
33%
Downstream Effectors
33%
ATP-binding Cassette Transporter A1 (ABCA1)
33%
Patients with Breast Cancer
33%
P-glycoprotein Expression
33%
Cytotoxic Agents
33%
Multidrug Resistance Protein 1 (MDR1)
33%
Effector Molecules
33%
Tumor Targeting
33%
Taxanes
33%
Brush Border
33%
Intestinal Epithelium
33%
Anatomic Location
33%
Anthracyclines
33%
Immunology and Microbiology
Multidrug Resistance
100%
P-Glycoprotein
33%
Multidrug Resistance Protein 1
16%
Blood Brain Barrier
16%
Brush Border
16%
ABCG2
16%
Gastrointestinal Epithelium
16%
Biochemistry, Genetics and Molecular Biology
Multidrug Resistance
100%
P-Glycoprotein
33%
Blood Brain Barrier
16%
Brush Border
16%
ABCG2
16%
P Glycoprotein 1
16%
Medicine and Dentistry
Anthracycline
16%
Breast Cancer Resistance Protein
16%
Multidrug Resistance Protein 1
16%
Brush Border
16%